V
Valeria De Arcangelis
Researcher at Agostino Gemelli University Polyclinic
Publications - 3
Citations - 48
Valeria De Arcangelis is an academic researcher from Agostino Gemelli University Polyclinic. The author has contributed to research in topics: Immunology & Fingolimod. The author has an hindex of 1, co-authored 3 publications receiving 3 citations.
Papers
More filters
Journal ArticleDOI
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies.
Fioravante Capone,Matteo Lucchini,Matteo Lucchini,Elisabetta Ferraro,Assunta Bianco,Assunta Bianco,Mariagrazia Rossi,Alessandra Cicia,Alessandra Cicia,Antonio Cortese,Alessandro Cruciani,Valeria De Arcangelis,Laura De Giglio,Francesco Motolese,Biagio Sancetta,Massimiliano Mirabella,Massimiliano Mirabella,Vincenzo Di Lazzaro +17 more
TL;DR: In this paper, the authors evaluated the immunogenicity and safety of mRNA COVID-19 vaccines in a convenience sample of 140 MS patients treated with different DMTs, undergoing vaccination between April and June 2021.
Journal ArticleDOI
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis
Matteo Lucchini,Matteo Lucchini,Lorenzo Maggi,Elena Pegoraro,Massimiliano Filosto,Carmelo Rodolico,Giovanni Antonini,Matteo Garibaldi,Maria Lucia Valentino,Gabriele Siciliano,Giorgio Tasca,Giorgio Tasca,Valeria De Arcangelis,Chiara De Fino,Massimiliano Mirabella,Massimiliano Mirabella +15 more
TL;DR: In this article, an autoantibody directed against the 5′-citosolic nucleotidase1A (cN1A) was identified in the sera of sporadic inclusion body myositis (s-IBM) patients with widely variable sensitivity (33%−76%) and specificity (87%−100%).
Journal ArticleDOI
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients
Assunta Bianco,Assunta Bianco,Matteo Lucchini,Matteo Lucchini,Rocco Totaro,Roberta Fantozzi,Giovanna De Luca,Sonia Di Lemme,Giorgia Presicce,Luana Evangelista,Valeria Di Tommaso,Roberta Pastorino,Chiara De Fino,Valeria De Arcangelis,Diego Centonze,Massimiliano Mirabella,Massimiliano Mirabella +16 more
TL;DR: In this article, the authors evaluated the frequency and predictors of disease reactivation in patients who stopped FTY for pregnancy and found that relapses during pregnancy were the only significant predictor for postpartum relapses.